Acute Myeloid Leukemia With NPM1 Mutation

Oncology

Prevalence

6.0 / 100K

Incidence

4.3 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Acute Myeloid Leukemia With NPM1 Mutation?

There are 1 clinical trial targeting Acute Myeloid Leukemia With NPM1 Mutation tracked by BioSniper.

What is the prevalence of Acute Myeloid Leukemia With NPM1 Mutation?

The estimated prevalence of Acute Myeloid Leukemia With NPM1 Mutation is approximately 6.0 per 100,000 population.

Deep-dive into Acute Myeloid Leukemia With NPM1 Mutation

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Acute Myeloid Leukemia With NPM1 Mutation — Drugs in Development & Clinical Trials | BioSniper